Author

Nicola Lungu

Observed names: Lungu, N, N Lungu, N. Lungu

Observed institutions: St Thomas' Hospital, Western General Hospital, London School of Hygiene & Tropical Medicine

OpenAlex ID: A5001481733

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

1 Patient acceptability and feasibility of HIV testing in emergency departments in the UK – a systematic review and meta-analysis

2017 · Nicola Lungu · Emergency Medicine Journal · 3

P191 With A Low Incidence Of Drug-induced Hepatitis, Should We Be Offering Latent Tb Treatment To More Patients Over The Age Of 35?

2014 · P. Howlett, N. Lungu, et al. · Thorax · 3

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

P77 Undiagnosed HIV: can at risk groups be identified for a new testing strategy?: Abstract P77 Table 1

2015 · Nicola Lungu, Sheila Morris, et al. · Sexually Transmitted Infections

Works count: 9

Citation count: 103

H-index: 4

I10-index: 3